Skip to content
Latest
Futures Trading: The Complete Guide For Beginners Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying. Layoffs with dignity? Why these tech companies are offering free laptops and LinkedIn Premium. Cybertruck’s run comes to an end as Musk kills off pricey pet project Trump administration’s cap on student loans have borrowers turning to private lenders Strive (ASST) Posts $474.8 Million Common Net Income as Bitcoin Yield Hits 63.2% DraftKings stock just lost 20%: the real story isn’t the earnings miss Stablecoin Inflow Reversal Fails to Confirm Crypto Recovery Futures Trading: The Complete Guide For Beginners Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying. Layoffs with dignity? Why these tech companies are offering free laptops and LinkedIn Premium. Cybertruck’s run comes to an end as Musk kills off pricey pet project Trump administration’s cap on student loans have borrowers turning to private lenders Strive (ASST) Posts $474.8 Million Common Net Income as Bitcoin Yield Hits 63.2% DraftKings stock just lost 20%: the real story isn’t the earnings miss Stablecoin Inflow Reversal Fails to Confirm Crypto Recovery
STOX.NEWS
In focus
POST 65 BTC 52 NDAQ 34 NXTT 28 NOV 24 TLDR 20 ETH 18 JST 16

Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.

MarketWatch
Image supplied by MarketWatch.
Advertisement
Demo creative for ADG7 Article top (728x90)

As part of the agreement, Hims said it won’t compound GLP-1 medications like Zepbound in the future.

Related video

Advertisement
Demo creative for ADG8 Article body (336x280)

More on this

Advertisement
Demo creative for ADG3 Footer banner (728x90)